AS
Astec LifeSciences Limited
ASTEC.NS · NSE
₹741.00 +5.15% (+₹36.30)
1M +27.58%
Market Cap ₹15.7B
P/E Ratio -
Div. Yield -
ROE 16.55%
Bulios Fair Price
₹383.4
48.3% downside
Current Price
₹741
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ASTEC.NS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
11 /100
Expensive EV/EBITDA 174.23x
P/S 3.56x
P/B 4.01x
Growth
0 /100
Declining Rev. growth 17.40%
Book val. growth 16.03%
EPS growth N/A
Profitability
7 /100
Weak Gross margin 12.54%
Net margin 15.11%
Op. margin 8.78%
Quality
0 /100
Poor ROE 16.55%
ROIC N/A
ROA N/A
Debt
76 /100
Low Debt/Equity 0.00x
Int. coverage -1.14x
Net debt/EBITDA 0.00x
Stability
38 /100
Moderate Beta 0.15x
Rev. volatility 9.96%
EPS volatility 106.81%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ASTEC.NS
Online
Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Anurag Roy
Employees
471
Headquarters
Mumbai
Upcoming events
23 OCT
Earnings
Upcoming earnings report